GITR and TIGIT immunotherapy provokes divergent multi-cellular responses in the tumor microenvironment of gastrointestinal cancers
Sathe, A.; Ayala, C.; Bai, X.; Grimes, S. M.; Lee, B.; Kin, C.; Shelton, A.; Poultsides, G.; Ji, H.
Show abstract
Understanding the cellular mechanisms of novel immunotherapy agents in the human tumor microenvironment (TME) is critical to their clinical success. We examined GITR and TIGIT immunotherapy in gastric and colon cancer patients using ex vivo slice tumor slice cultures derived from cancer surgical resections. This primary culture system maintains the original TME in a near-native state. We applied paired single-cell RNA and TCR sequencing to identify cell type specific transcriptional reprogramming. The GITR agonist was limited to increasing effector gene expression only in cytotoxic CD8 T cells. The TIGIT antagonist increased TCR signaling and activated both cytotoxic and dysfunctional CD8 T cells, including clonotypes indicative of potential tumor antigen reactivity. The TIGIT antagonist also activated T follicular helper-like cells and dendritic cells, and reduced markers of immunosuppression in regulatory T cells. Overall, we identified cellular mechanisms of action of these two immunotherapy targets in the patients TME.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Enhancing CAR-T Cell Metabolism to Overcome Hypoxic Conditions in the Brain Tumor Microenvironment 95%
- Tertiary lymphoid structures induced by CXCL13-producing CD4+ T cells increase tumor infiltrating CD8+ T cells and B cells in ovarian cancer 95%
- Single-cell transcriptomics of allo-reactive CD4+ T cells over time reveals divergent fates during gut GVHD 94%
Similar papers in this journal
- Single cell genomic characterization reveals the cellular reprogramming of the gastric tumor microenvironment 97%
- Myeloid cell-associated resistance to PD-1/PD-L1 blockade in urothelial cancer revealed through bulk and single-cell RNA sequencing 96%
- Immunogenicity of non-canonical HLA-tumor ligands identified through proteogenomics 95%
Similar papers in this journal
- KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response 96%
- Spatial colocalization and combined survival benefit of natural killer and CD8 T cells despite profound MHC class I loss in non-small cell lung cancer 95%
- B cell c-Maf signaling promotes tumor progression in animal models of pancreatic cancer and melanoma 95%
Similar papers in this journal
- DUSP11 is an intracellular innate immune checkpoint in lung adenocarcinoma 95%
- Tertiary lymphoid structures are associated with enhanced macrophage activation, immune checkpoint expression and predict outcome in cervical cancer. 95%
- The spatial structure of the tumor immune microenvironment can explain and predict patient response in high-grade serous carcinoma 95%
Similar papers in this journal
- Leveraging Allele-Specific Expression for Therapeutic Response Gene Discovery in Glioblastoma. 96%
- Natural killer cell regulation of breast cancer stem cells mediates metastatic dormancy. 95%
- Quantifying T- and B-cell immune receptor distribution diversity to uncover their clinical relevance in clear cell renal cell carcinoma 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.